E Lanino

Author PubWeight™ 41.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005 1.86
2 Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J Med Genet 2005 1.63
3 The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet 2001 1.29
4 Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplant 2000 1.24
5 Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001 1.24
6 Severe neurologic complications after hematopoietic stem cell transplantation in children. Neurology 2002 1.07
7 Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group. Bone Marrow Transplant 1996 1.03
8 Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia 2002 1.03
9 Bone marrow transplantation for neuroblastoma: a review of 509 cases. EBMT Group. Bone Marrow Transplant 1989 1.01
10 Mesial temporal sclerosis--a late complication in four allogeneic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicity. Bone Marrow Transplant 2003 0.98
11 Incidence of bacteremias and invasive mycoses in children undergoing allogeneic hematopoietic stem cell transplantation: a single center experience. Bone Marrow Transplant 2007 0.95
12 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients. Br J Cancer 1999 0.93
13 Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma. Q J Nucl Med 1995 0.91
14 Long-term follow-up of two children with a variant of mild autosomal recessive osteopetrosis undergoing bone marrow transplantation. Bone Marrow Transplant 2000 0.90
15 Bacillus sphaericus bacteraemia in children with cancer: case reports and literature review. J Hosp Infect 2001 0.90
16 Myeloablative therapy and unpurged autologous bone marrow transplantation for poor-prognosis neuroblastoma: report of 34 cases. J Clin Oncol 1991 0.89
17 Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine. Cancer 1991 0.88
18 High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation. Bone Marrow Transplant 2001 0.88
19 Allogeneic bone marrow transplantation for Pearson's syndrome. Bone Marrow Transplant 2007 0.87
20 Impact of thrombotic thrombocytopenic purpura on leukemic children undergoing bone marrow transplantation. Bone Marrow Transplant 2000 0.85
21 Transplant-related toxicity and mortality: an AIEOP prospective study in 636 pediatric patients transplanted for acute leukemia. Bone Marrow Transplant 2002 0.83
22 Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation. Bone Marrow Transplant 2001 0.83
23 Low CD4 lymphocyte count in a patient with P. carinii pneumonia after autologous bone marrow transplantation. Bone Marrow Transplant 1995 0.82
24 Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer. J Chemother 1999 0.82
25 Immunohistochemical study of skin lesions in acute and chronic graft versus host disease following bone marrow transplantation. Am J Surg Pathol 1997 0.81
26 Invasive mycoses in children receiving hemopoietic SCT. Bone Marrow Transplant 2008 0.81
27 Cytogenetic and molecular study of two human neuroblastoma cell lines. Cancer Genet Cytogenet 1988 0.81
28 Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children. Bone Marrow Transplant 2009 0.81
29 Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience. Bone Marrow Transplant 2008 0.80
30 Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder. J Chemother 2007 0.79
31 Shifting from open surgical cut down to ultrasound-guided percutaneous central venous catheterization in children: learning curve and related complications. Pediatr Surg Int 2010 0.79
32 Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Group (GITMO). Haematologica 2001 0.78
33 Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group. J Clin Oncol 1999 0.78
34 [Sertoli-Leydig cell tumor with a retiform pattern: description of a case]. Pediatr Med Chir 1993 0.78
35 Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation. J Antimicrob Chemother 1991 0.78
36 Bacteremias in children receiving hemopoietic SCT. Bone Marrow Transplant 2008 0.78
37 Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patients. Anticancer Res 1990 0.78
38 Update on extracorporeal photochemotherapy for graft-versus-host disease treatment. Bone Marrow Transplant 2005 0.78
39 Meiotic origin of trisomy in neoplasms: evidence in a case of erythroleukaemia. Leukemia 2001 0.77
40 Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant. J Chemother 2009 0.77
41 Autologous bone marrow transplantation in children with acute myeloblastic leukemia: report from the Italian National Pediatric Registry (AIEOP-BMT). Bone Marrow Transplant 1996 0.77
42 Impact of marrow unrelated donor search duration on outcome of children with acute lymphoblastic leukemia in second remission. Bone Marrow Transplant 2003 0.76
43 Clonal analysis of peripheral blood lymphocytes from three patients with advanced neuroblastoma receiving recombinant interleukin-2 and interferon alpha. Cancer Immunol Immunother 1993 0.76
44 High-dose chemotherapy with autologous bone marrow rescue in advanced stage IV neuroblastoma. Eur J Cancer 1993 0.76
45 Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation. Bone Marrow Transplant 1999 0.76
46 Rationale and results of the International Society of Pediatric Oncology (SIOP) Italian pilot study on childhood hepatoma: surgical resection d'emblée or after primary chemotherapy? J Surg Oncol Suppl 1993 0.75
47 Strategies for management of cytomegalovirus (CMV) infection after allogeneic bone marrow transplantation: the "doubling of baseline CMV pp65 antigenemia" and the "cidofovir as rescue treatment approaches. Blood 2001 0.75
48 Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party. Bone Marrow Transplant 1996 0.75
49 [Italian multicenter experience in the treatment of neuroblastoma and soft tissue sarcoma]. Minerva Pediatr 1985 0.75
50 G-CSF primed peripheral blood progenitor cells (PBPC) autotransplantation in stage IV Neuroblastoma and poor risk solid tumors. Bone Marrow Transplant 1996 0.75
51 Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD. Bone Marrow Transplant 2010 0.75
52 [Autologous bone marrow transplantation in children. Use of parenteral nutrition]. Pediatr Med Chir 1987 0.75
53 Nitazoxanide or CD3+/CD4+ lymphocytes for recovery from severe Cryptosporidium infection after allogeneic bone marrow transplant? Pediatr Transplant 2007 0.75
54 [Omphalocele: 10-year-experience]. Pediatr Med Chir 1985 0.75
55 [High-dose chemotherapy, G-CSF and the use of peripheral blood progenitor cells in patients with poor-prognosis neuroblastoma]. Pediatr Med Chir 1994 0.75
56 Unrelated donor marrow transplantation: an update of the experience of the Italian Bone Marrow Transplant Group (GITMO). Haematologica 2000 0.75
57 Prophylaxis of streptococcal bacteraemia with oral penicillin V in children undergoing bone marrow transplantation. Support Care Cancer 1995 0.75
58 Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinum. Med Pediatr Oncol 1987 0.75
59 [Sepsis related to a permanent central venous catheter in children with neoplastic disease: practical implications of a continuous surveillance of the etiology]. Pediatr Med Chir 1997 0.75
60 Rare viral infections in children receiving hemopoietic stem cell transplant. Bone Marrow Transplant 2008 0.75
61 Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplant. Bone Marrow Transplant 1998 0.75
62 [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma]. Pediatr Med Chir 1987 0.75
63 Unrelated donor marrow transplantation: initial experience of the Italian bone marrow transplant group (GITMO). Bone Marrow Transplant 1996 0.75
64 [Transplantation of bone marrow from unrelated donors in Italy: activity and results]. Ann Ist Super Sanita 1999 0.75
65 Unpurged ABMT for neuroblastoma: AIEOP-BMT experience. Bone Marrow Transplant 1991 0.75
66 Unpurged autologous bone marrow transplantation for neuroblastoma: the AIEOP-BMT group experience. Bone Marrow Transplant 1991 0.75
67 Hepatic and splenic mycosis in children with acute leukemia. Haematologica 1992 0.75
68 Diagnostic and therapeutic use of 131I-metaiodobenzylguanidine in children with neuroblastoma. J Nucl Med Allied Sci 1988 0.75
69 Early infectious complications in children undergoing BMT. Bone Marrow Transplant 1991 0.75
70 Phase II study of recombinant human granulocyte colony-stimulating factor in children undergoing bone marrow transplantation. Bone Marrow Transplant 1996 0.75
71 Unrelated donor marrow transplantation for inborn errors. Bone Marrow Transplant 1998 0.75
72 A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytes. J Natl Cancer Inst 1985 0.75
73 Unrelated donor marrow transplantation for chronic myelogenous leukaemia. Br J Haematol 1998 0.75
74 Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin. Cancer Chemother Pharmacol 1988 0.75
75 MYCN amplification does not affect survival of neuroblastoma patients treated with autologous bone marrow transplantation. Bone Marrow Transplant 1991 0.75
76 Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: a pediatric experience. Pediatr Transplant 2008 0.75
77 Growth and endocrine assessment in children undergoing bone marrow transplant: the 'G. Gaslini' experience. Bone Marrow Transplant 1991 0.75
78 Health status of long term survivors after myeloablative therapy and bone marrow transplantation in children. Bone Marrow Transplant 1996 0.75
79 Failure of cidofovir to reduce CMV-antigenemia in a child transplanted from a matched unrelated donor. J Chemother 2001 0.75